|
1
|
Mirabello L, Troisi RJ and Savage SA:
International osteosarcoma incidence patterns in children and
adolescents, middle ages and elderly persons. Int J Cancer.
125:229–234. 2009.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Kumar R, Kumar M, Malhotra K and Patel S:
Primary osteosarcoma in the elderly revisited: Current concepts in
diagnosis and treatment. Curr Oncol Rep. 20(13)2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Harrison DJ, Geller DS, Gill JD, Lewis VO
and Gorlick R: Current and future therapeutic approaches for
osteosarcoma. Expert Rev Anticancer Ther. 18:39–50. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Shaikh AB, Li F, Li M, He B, He X, Chen G,
Guo B, Li D, Jiang F, Dang L, et al: Present advances and future
perspectives of molecular targeted therapy for osteosarcoma. Int J
Mol Sci. 17(506)2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Zhang B and Zhang Y, Li R, Li J, Lu X and
Zhang Y: The efficacy and safety comparison of first-line
chemotherapeutic agents (high-dose methotrexate, doxorubicin,
cisplatin, and ifosfamide) for osteosarcoma: A network
meta-analysis. J Orthop Surg Res. 15(51)2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Luetke A, Meyers PA, Lewis I and Juergens
H: Osteosarcoma treatment-where do we stand? A state of the art
review. Cancer Treat Rev. 40:523–532. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Rinn JL and Chang HY: Genome regulation by
long noncoding RNAs. Annu Rev Biochem. 81:145–166. 2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zhang Q, Geng PL, Yin P, Wang XL, Jia JP
and Yao J: Down-regulation of long non-coding RNA TUG1 inhibits
osteosarcoma cell proliferation and promotes apoptosis. Asian Pac J
Cancer Prev. 14:2311–2315. 2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Li H, Cui J, Xu B, He S, Yang H and Liu L:
Long non-coding RNA XIST serves an oncogenic role in osteosarcoma
by sponging miR-137. Exp Ther Med. 17:730–738. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Liu P, He W, Lu Y and Wang Y: Long
non-coding RNA LINC00152 promotes tumorigenesis via sponging
miR-193b-3p in osteosarcoma. Oncol Lett. 18:3630–3636.
2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zhang H, Lu Y, Wang J, Zhang T, Dong C, Li
X, Wang X, Ma Q, Yang T and Zhou Y: Downregulation of the long
non-coding RNA FOXD2-AS1 inhibits cell proliferation, migration and
invasion in osteosarcoma. Mol Med Rep. 20:292–302. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Deng R, Zhang J and Chen J: lncRNA SNHG1
negatively regulates miRNA-101-3p to enhance the expression of
ROCK1 and promote cell proliferation, migration and invasion in
osteosarcoma. Int J Mol Med. 43:1157–1166. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Jiang Z, Jiang C and Fang J: Up-regulated
lnc-SNHG1 contributes to osteosarcoma progression through
sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin
pathway. Biochem Biophys Res Commun. 495:238–245. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wang J, Cao L, Wu J and Wang Q: Long
non-coding RNA SNHG1 regulates NOB1 expression by sponging miR-326
and promotes tumorigenesis in osteosarcoma. Int J Oncol. 52:77–88.
2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Lu TX and Rothenberg ME: MicroRNA. J
Allergy Clin Immunol. 141:1202–1207. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Fei D, Sui G, Lu Y, Tan L, Dongxu Z and
Zhang K: The long non-coding RNA-ROR promotes osteosarcoma
progression by targeting miR-206. J Cell Mol Med. 23:1865–1872.
2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Cheng Z, Shu H, Cui Y, Zhang Q, Zhao B,
Pan D, Chao Q and Wang D: MiR-424-5p inhibits proliferation,
invasion and promotes apoptosis and predicts good prognosis in
glioma by directly targeting BFAR. Pathol Oncol Res. 26:2327–2335.
2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Wu JB, Yang B, Zhang Y, Feng X, He B, Xie
H, Zhou L, Wu J and Zheng S: miR-424-5p represses the metastasis
and invasion of intrahepatic cholangiocarcinoma by targeting ARK5.
Int J Biol Sci. 15:1591–1599. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wang K, Zhu G, Bao S and Chen S: Long
non-coding RNA LINC00511 mediates the effects of ESR1 on
proliferation and invasion of ovarian cancer through miR-424-5p and
miR-370-5p. Cancer Manag Res. 11:10807–10819. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Long XH, Mao JH, Peng AF, Zhou Y, Huang SH
and Liu ZL: Tumor suppressive microRNA-424 inhibits osteosarcoma
cell migration and invasion via targeting fatty acid synthase. Exp
Ther Med. 5:1048–1052. 2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Huang Y, Liu W, He B, Wang L, Zhang F, Shu
H and Sun L: Exosomes derived from bone marrow mesenchymal stem
cells promote osteosarcoma development by activating oncogenic
autophagy. J Bone Oncol. 21(100280)2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Yang C, Wu K, Wang S and Wei G: Long
non-coding RNA XIST promotes osteosarcoma progression by targeting
YAP via miR-195-5p. J Cell Biochem. 119:5646–5656. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zhao J, Zhang C, Gao Z, Wu H, Gu R and
Jiang R: Long non-coding RNA ASBEL promotes osteosarcoma cell
proliferation, migration, and invasion by regulating microRNA-21. J
Cell Biochem. 119:6461–6469. 2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Xu R, Feng F, Yu X, Liu Z and Lao L:
LncRNA SNHG4 promotes tumour growth by sponging miR-224-3p and
predicts poor survival and recurrence in human osteosarcoma. Cell
Prolif. 51(e12515)2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Dong P, Xiong Y, Yue J, Hanley SJB and
Watari H: miR-34a, miR-424 and miR-513 inhibit MMSET expression to
repress endometrial cancer cell invasion and sphere formation.
Oncotarget. 9:23253–23263. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wang J, Wang S, Zhou J and Qian Q:
miR-424-5p regulates cell proliferation, migration and invasion by
targeting doublecortin-like kinase 1 in basal-like breast cancer.
Biomed Pharmacother. 102:147–152. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Fang Y, Liang X, Xu J and Cai X: miR-424
targets AKT3 and PSAT1 and has a tumor-suppressive role in human
colorectal cancer. Cancer Manag Res. 10:6537–6547. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Shekhar R, Priyanka P, Kumar P, Ghosh T,
Khan MM, Nagarajan P and Saxena S: The microRNAs miR-449a and
miR-424 suppress osteosarcoma by targeting cyclin A2 expression. J
Biol Chem. 294:4381–4400. 2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Yamanaka Y, Friess H, Buchler M, Beger HG,
Uchida E, Onda M, Kobrin MS and Korc M: Overexpression of acidic
and basic fibroblast growth factors in human pancreatic cancer
correlates with advanced tumor stage. Cancer Res. 53:5289–5296.
1993.PubMed/NCBI
|
|
31
|
Berger W, Setinek U, Mohr T, Kindas-Mügge
I, Vetterlein M, Dekan G, Eckersberger F, Caldas C and Micksche M:
Evidence for a role of FGF-2 and FGF receptors in the proliferation
of non-small cell lung cancer cells. Int J Cancer. 83:415–423.
1999.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Gazzaniga P, Gandini O, Gradilone A,
Silvestri I, Giuliani L, Magnanti M, Gallucci M, Saccani G, Frati L
and Agliano AM: Detection of basic fibroblast growth factor mRNA in
urinary bladder cancer: Correlation with local relapses. Int J
Oncol. 14:1123–1127. 1999.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Zhang QH, Xu P, Lu YX and Dou HT: Acidic
and basic fibroblast growth factor expression levels in cervical
cancer and their effects on tumor cell proliferation. Genet Mol
Res. 15:2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Cheng Z, Ma R, Tan W and Zhang L: MiR-152
suppresses the proliferation and invasion of NSCLC cells by
inhibiting FGF2. Exp Mol Med. 46(e112)2014.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Sun XH, Geng XL, Zhang J and Zhang C:
miRNA-646 suppresses osteosarcoma cell metastasis by downregulating
fibroblast growth factor 2 (FGF2). Tumour Biol. 36:2127–2134.
2015.PubMed/NCBI View Article : Google Scholar
|
